Toshifumi Hibi

Keio University

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

SciProfiles

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Keio University

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Research Subjects

Research Interests

Toshifumi Hibi has a total of 437 co-authors. Here are the top co-authors by number of shared publications:

Hidekazu Suzuki
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
54 shared publications
Tadakazu Hisamatsu
Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan
40 shared publications
Takanori Kanai
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
40 shared publications
Juntaro Matsuzaki
Division of Interdisciplinary Genetics and Nanomedicine, Research Center for Drug Discovery Keio University Faculty of Pharmacy Tokyo Japan
32 shared publications
Hitoshi Tsugawa
Keio University School of Medicine
31 shared publications
Haruhiko Ogata
Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Tokyo, Japan
30 shared publications

Latest Publications

Sort by

Website
Google Scholar
- 1 June 2018
- Published by Elsevier in Gastrointestinal Endoscopy
Su1675 DEVELOPING A COLON CAPSULE ENDOSCOPY SCORE TO ASSESS THE SEVERITY OF ULCERATIVE COLITIS: THE CAPSULE SCORING OF ULCERATIVE COLITIS (CSUC)
by Naoki Hosoe, Masaru Nakano, Ken Takeuchi, Yutaka Endo, Katsuyoshi Matsuoka, Teppei Omori, Mari Hayashida, Taku Kobayashi, Atsushi Yoshida, Shinta Mizuno, et al.
Website
Google Scholar
- 1 June 2018
- Published by Elsevier in Gastrointestinal Endoscopy
Su1675 DEVELOPING A COLON CAPSULE ENDOSCOPY SCORE TO ASSESS THE SEVERITY OF ULCERATIVE COLITIS: THE CAPSULE SCORING OF ULCERATIVE COLITIS (CSUC)
by Naoki Hosoe, Masaru Nakano, Ken Takeuchi, Yutaka Endo, Katsuyoshi Matsuoka, Teppei Omori, Mari Hayashida, Taku Kobayashi, Atsushi Yoshida, Shinta Mizuno, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis
by Mamoru Watanabe, Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Masataka Igeta, Kazunori Oda, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis
by Mamoru Watanabe, Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Masataka Igeta, Kazunori Oda, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Mo1902 - Non-Adherence of IBD Medications and Disease Activity During Pregnancy and Pregnancy Outcomes -A Multicenter Study-
by Chikako Watanabe, Motohiro Esaki, Kenji Watanabe, Shiro Nakamura, Noriko Kamata, Hirokazu Yamagami, Kaoru Yokoyama, Naoki Yoshimura, Toshimitsu Fujii, Katsuyoshi Matsuoka, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Mo1902 - Non-Adherence of IBD Medications and Disease Activity During Pregnancy and Pregnancy Outcomes -A Multicenter Study-
by Chikako Watanabe, Motohiro Esaki, Kenji Watanabe, Shiro Nakamura, Noriko Kamata, Hirokazu Yamagami, Kaoru Yokoyama, Naoki Yoshimura, Toshimitsu Fujii, Katsuyoshi Matsuoka, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Sa1768 - Clinical Factors Associated with Discontinuation of Combo or Monotherapy for Crohn's Disease: A Sub-Analysis of a Prospective Radomized Clinical Trial (Diamond Study)
by Tadakazu Hisamatsu, Takayuki Matsumoto, Kenji Watanabe, Hiroshi Nakase, Satoshi Motoya, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Motohiro Esaki, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Sa1768 - Clinical Factors Associated with Discontinuation of Combo or Monotherapy for Crohn's Disease: A Sub-Analysis of a Prospective Radomized Clinical Trial (Diamond Study)
by Tadakazu Hisamatsu, Takayuki Matsumoto, Kenji Watanabe, Hiroshi Nakase, Satoshi Motoya, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Motohiro Esaki, et al.
Website
Google Scholar
Cited by 6
- 1 May 2018
- Published by Elsevier in Gastroenterology
Sa1749 - Indigo Naturalis is Effective in Treatment-Refractory Patients with Ulcerative Colitis: Post-HOC Analysis from Indigo Study
by Makoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, Taku Kobayashi, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Kenji Watanabe, Takayuki Abe, Toshifumi Hibi, Yasuo Suzuki, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Sa1749 - Indigo Naturalis is Effective in Treatment-Refractory Patients with Ulcerative Colitis: Post-HOC Analysis from Indigo Study
by Makoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, Taku Kobayashi, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Kenji Watanabe, Takayuki Abe, Toshifumi Hibi, Yasuo Suzuki, et al.
Cited by 6
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Mo1863 - Multiple Ascending Dose, Open-Label, Phase 1/2 Study of E6011, an Anti-Fractalkine Monoclonal Antibody, to Investigate the Safety and Clinical Response in Patients with Crohn's Disease
by Satoshi Tanida, Katsuyoshi Matsuoka, Makoto Naganuma, Kazuya Kitamura, Toshiyuki Matsui, Makoto Arai, Mikihiro Fujiya, Noriyuki Horiki, Hiroko Nebiki, Fukunori Kinjo, et al.
Website
Google Scholar
- 1 May 2018
- Published by Elsevier in Gastroenterology
Mo1863 - Multiple Ascending Dose, Open-Label, Phase 1/2 Study of E6011, an Anti-Fractalkine Monoclonal Antibody, to Investigate the Safety and Clinical Response in Patients with Crohn's Disease
by Satoshi Tanida, Katsuyoshi Matsuoka, Makoto Naganuma, Kazuya Kitamura, Toshiyuki Matsui, Makoto Arai, Mikihiro Fujiya, Noriyuki Horiki, Hiroko Nebiki, Fukunori Kinjo, et al.
Website
Google Scholar
- 1 May 2017
- Published by Elsevier in Gastrointestinal Endoscopy
Sa1712 Comparison of Endoscopic Responses to Adalimumab Monotherapy and Combination Therapy With Azathioprine in Patients With Crohn's Disease: A Sub-Analysis of Diamond Trial
by Kenji Watanabe, Takayuki Matsumoto, Satoshi Motoya, Tadakazu Hisamatsu, Hiroshi Nakase, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Masakazu Nagahori, et al.
Website
Google Scholar
- 1 May 2017
- Published by Elsevier in Gastrointestinal Endoscopy
Sa1712 Comparison of Endoscopic Responses to Adalimumab Monotherapy and Combination Therapy With Azathioprine in Patients With Crohn's Disease: A Sub-Analysis of Diamond Trial
by Kenji Watanabe, Takayuki Matsumoto, Satoshi Motoya, Tadakazu Hisamatsu, Hiroshi Nakase, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Masakazu Nagahori, et al.
Website
Google Scholar
- 1 April 2017
- Published by Elsevier in Gastroenterology
Association Between Pharmacokinetics of Adalimumab and Disease Outcome in Japanese Patients with Biologics Naïve Crohn's Disease: A Subanalysis of Diamond Study
by Hiroshi Nakase, Satoshi Motoya, Takayuki Matsumoto, Kenji Watanabe, Tadakazu Hisamatsu, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Motohiro Esaki, et al.
Website
Google Scholar
- 1 April 2017
- Published by Elsevier in Gastroenterology
Association Between Pharmacokinetics of Adalimumab and Disease Outcome in Japanese Patients with Biologics Naïve Crohn's Disease: A Subanalysis of Diamond Study
by Hiroshi Nakase, Satoshi Motoya, Takayuki Matsumoto, Kenji Watanabe, Tadakazu Hisamatsu, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Motohiro Esaki, et al.
Website
Google Scholar
- 1 April 2016
- Published by Elsevier in Gastroenterology
Sa1946 Factors Associated With the First Trough Level of Infliximab at Week 2 That Predicts Short- and Long-Term Outcomes in Ulcerative Colitis
by Taku Kobayashi, Yasuo Suzuki, Satoshi Motoya, Fumihito Hirai, Haruhiko Ogata, Hiroaki Ito, Noriko Sato, Kunihiko Ozaki, Mamoru Watanabe, Toshifumi Hibi
Website
Google Scholar
- 1 April 2016
- Published by Elsevier in Gastroenterology
Sa1946 Factors Associated With the First Trough Level of Infliximab at Week 2 That Predicts Short- and Long-Term Outcomes in Ulcerative Colitis
by Taku Kobayashi, Yasuo Suzuki, Satoshi Motoya, Fumihito Hirai, Haruhiko Ogata, Hiroaki Ito, Noriko Sato, Kunihiko Ozaki, Mamoru Watanabe, Toshifumi Hibi
Website
Google Scholar
Cited by 2
- 1 April 2016
- Published by Elsevier in Gastroenterology
Mo1890 Safety, Tolerability and Efficacy of E6011, Anti-Human Fractalkine Monoclonal Antibody, in the First-in-Patient Study for Crohn's Disease
by Katsuyoshi Matsuoka, Makoto Naganuma, Toshiyuki Matsui, Makoto Arai, Satoshi Tanida, Kazuya Kitamura, Noriyuki Horiki, Mikihiro Fujiya, Masaki Iimuro, Keiichi Mitsuyama, et al.
Website
Google Scholar
- 1 April 2016
- Published by Elsevier in Gastroenterology
Mo1890 Safety, Tolerability and Efficacy of E6011, Anti-Human Fractalkine Monoclonal Antibody, in the First-in-Patient Study for Crohn's Disease
by Katsuyoshi Matsuoka, Makoto Naganuma, Toshiyuki Matsui, Makoto Arai, Satoshi Tanida, Kazuya Kitamura, Noriyuki Horiki, Mikihiro Fujiya, Masaki Iimuro, Keiichi Mitsuyama, et al.
Cited by 2

Show all